[Patient - Centered Care: A proposal for the implementation of the Advance Care Planning (ACP) in Neurocognitive Disorders from the perspective of Family Medicine].

Semergen

Departamento de Medicina Familiar y Salud Pública, Facultad de Medicina, Universidad de La Sabana, Chía, Cundinamarca, Colombia.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In recent years, the increasing older adult population and the high prevalence of neurocognitive disorders hace led to a significant demographic shift, resulting in greater functional dependence and challenges in end - of - life decision - making. In response to this reality, the importance of Advance Care Planning (ACP) is emphasized as a key strategy to ensure that medical management aligns with patient preferences. This study aims to analyze ACP from a family medicine perspective, identifying its benefits, barriers and implementation strategies in patients with neurocognitive disorders though an application protocol based on person - centered care and a holistic approach. Through a narrative review, 27 articles on ACP in primary care were selected. The main stakeholders identified include the patient, the surrogate decision maker, and the family physician. Furthermore, the study proposes the development of a protocol to facilitate the integration of ACP into routine medical consultations, ensuring its incorporation into clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semerg.2025.102517DOI Listing

Publication Analysis

Top Keywords

neurocognitive disorders
12
centered care
8
advance care
8
care planning
8
planning acp
8
care
5
acp
5
[patient centered
4
care proposal
4
proposal implementation
4

Similar Publications

Background: Alzheimer's disease (AD) patients and animal models exhibit an altered gut microbiome that is associated with pathological changes in the brain. Intestinal miRNA enters bacteria and regulates bacterial metabolism and proliferation. This study aimed to investigate whether the manipulation of miRNA could alter the gut microbiome and AD pathologies.

View Article and Find Full Text PDF

Introduction: Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia. We investigate associations among cardiovascular and metabolic disorders (hypertension, diabetes mellitus, and hyperlipidemia) and diagnosis (normal; amnestic [aMCI]; and non-amnestic [naMCI]).

Methods: Multinomial logistic regressions of participant data (N = 8737; age = 70.

View Article and Find Full Text PDF

The ketogenic diet (KD), a high-fat, low-carbohydrate regimen, has been shown to exert neuroprotective effects in various neurological models. This study explored how KD-alone or combined with antibiotic-induced gut microbiota depletion-affects cognition and neuroinflammation in aging. Thirty-two male rats (22 months old) were assigned to four groups (n = 8): control diet (CD), ketogenic diet (KD), antibiotics with control diet (AB), and antibiotics with KD (KDAB).

View Article and Find Full Text PDF

A ketogenic diet (KD) has shown promise as an adjunctive therapy for neurological and neuropsychiatric disorders, including bipolar disorder and major depressive disorder (MDD). We examined tolerance for a KD in young adults with MDD and assessed symptoms of depression and metabolic health. Students (n = 24) with a confirmed diagnosis of MDD at baseline receiving standard of care counseling and/or medication treatment were enrolled in a 10-12 week KD intervention that included partial provision of ketogenic-appropriate food items, frequent dietary counseling, and daily morning tracking of capillary R-beta-hydroxybutyrate (R-BHB).

View Article and Find Full Text PDF

Visceral adiposity has been proposed to be closely linked to cognitive impairment. This cross-sectional study aimed to evaluate the predictive value of Chinese Visceral Adiposity Index (CVAI) for mild cognitive impairment (MCI) in patients with type 2 diabetes mellitus (T2DM) and to develop a quantitative risk assessment model. A total of 337 hospitalized patients with T2DM were included and randomly assigned to a training cohort (70%, n = 236) and a validation cohort (30%, n = 101).

View Article and Find Full Text PDF